Search

Your search keyword '"Ferron, G. A."' showing total 559 results

Search Constraints

Start Over You searched for: Author "Ferron, G. A." Remove constraint Author: "Ferron, G. A."
559 results on '"Ferron, G. A."'

Search Results

101. What is the best management for a spermatic cord sarcoma in 2018?

102. P165 Comparison of postoperative complications and quality of life between patients undergoing continent versus non-continent urinary diversion after pelvic exenteration

105. EP781 Predictive risk factors of acute kidney injury after cytoreductive surgery and cisplatin-based hyperthermic intraperitoneal chemotherapy for ovarian peritoneal carcinomatosis

109. EP1275 Concordance of peritoneal cancer index using a two-step surgical protocol to select patients for cytoreductive surgery in ovarian cancer

110. Improved survival with secondary surgery in a reference center after a first R1 or R2 resection in soft tissue sarcoma (STS) of the limbs or trunk wall: An analysis 10931 patients (pts) in NETSARC

111. Surrogate endpoint of progression-free (PFS) and overall survival (OS) for advanced ovarian cancer (AOC) patients (pts) treated with neo-adjuvant chemotherapy (NACT): Results of the CHIVA randomized phase II GINECO study

112. Tumour microvessel density for predicting nintedanib activity: Data from the randomized CHIVA trial (a GINECO study)

113. Impact of abstention of diagnostic biopsy in sarcoma

114. Comparison of 11 circulating miRNAs and CA125 kinetics in ovarian cancer during first line treatment: Data from the randomized CHIVA trial (a GINECO-GCIG study)

115. CHIP et cancer de l’ovaire

116. 148 Senticol III: international validation study of sentinel node biopsy in early cervical cancer. A gineco, engot and gcig study

117. Correction to: Surgery in reference centers improves survival of sarcoma patients: a nationwide study

123. Is there an oncological interest in the combination of CRS/HIPEC for peritoneal carcinomatosis of HCC? Results of a multicenter international study

124. Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study

125. Can we cure patients with abdominal desmoplastic small round cell tumor? Results of a retrospective multicentric study on 100 patients

126. Need for a stratified analysis in stage I malignant ovarian germ cell tumors (MOGCT): Prospective survival analysis of cases collection from the French rare malignant ovarian tumors (TMRO) network & GINECO group

127. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendicular and extra-appendicular origin

128. Analysis of the orientational order effect on n-alkanes: Evidences on experimental response functions and description using Monte Carlo molecular simulation.

129. Disseminated ovarian Growing Teratoma Syndrome: a case report highlighting surgical safety issues

131. Immunohistochemical evaluation of two antibodies against PD-L1 and prognostic significance of PD-L1 expression in epithelioid peritoneal malignant mesothelioma: A RENAPE study

132. High dose (54 Gy) Pre-operative Tomotherapy for Retroperitoneal Liposarcoma: Results of a Phase 2 Multicenter Study

133. Improved overall and progression free survival after surgery in expert sites for sarcoma patients: A nationwide study of FSG-GETO/NETSARC

134. Abstract S2-07: Sentinel node detection after neoadjuvant chemotherapy in patient without previous axillary node involvement (GANEA 2 trial): Follow-up of a prospective multi-institutional cohort

135. 1672PD - Improved survival with secondary surgery in a reference center after a first R1 or R2 resection in soft tissue sarcoma (STS) of the limbs or trunk wall: An analysis 10931 patients (pts) in NETSARC

137. 1945P - Comparison of 11 circulating miRNAs and CA125 kinetics in ovarian cancer during first line treatment: Data from the randomized CHIVA trial (a GINECO-GCIG study)

139. 1016P - Surrogate endpoint of progression-free (PFS) and overall survival (OS) for advanced ovarian cancer (AOC) patients (pts) treated with neo-adjuvant chemotherapy (NACT): Results of the CHIVA randomized phase II GINECO study

140. Étude observationnelle analytique de la chirurgie d'ablation compartimentale à visée curative des liposarcomes du rétropéritoine.

142. The CHIVA study: a GINECO randomized double blind phase II trial of nintedanib versus placebo with the neo-adjuvant chemotherapy (NACT) strategy for patients (pts) with advanced unresectable ovarian cancer (OC). Report of the interval debulking surgery (IDS) safety outcome

143. Diffuse malignant peritoneal mesothelioma: Evaluation of systemic chemotherapy with comprehensive treatment through the RENAPE Database

144. A new internet tool to report peritoneal malignancy extent. PeRitOneal MalIgnancy Stage Evaluation (PROMISE) application

145. EP-1398: Acute gastro-intestinal toxicities after pre-operative tomotherapy for retroperitoneal liposarcoma

147. Laparoscopic hysterectomy after concurrent radiochemotherapy in locally advanced cervical cancer compared to laparotomy: A multi institutional prospective pilot study of cost, surgical outcome and quality of life

149. 938PD - Need for a stratified analysis in stage I malignant ovarian germ cell tumors (MOGCT): Prospective survival analysis of cases collection from the French rare malignant ovarian tumors (TMRO) network & GINECO group

Catalog

Books, media, physical & digital resources